Fny Investment Advisers, LLC Enveric Biosciences, Inc. Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022
SELL
$12.5 - $52.0 $500 - $2,080
-40 Closed
0 $0
Q3 2021

Oct 13, 2021
SELL
$80.5 - $175.0 $241,500 - $525,000
-3,000 Reduced 98.68%
40 $0
Q2 2021

Jul 14, 2021
BUY
$95.0 - $156.5 $285,000 - $469,500
3,000 Added 7500.0%
3,040 $7,000
Q1 2021

Apr 12, 2021
BUY
$131.5 - $245.0 $5,260 - $9,800
40 New
40 $0

About Enveric Biosciences, Inc.

ENVB Quotes by TradingView
  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $686K
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email